tiprankstipranks
Trending News
More News >
Novartis (DE:NOT)
XETRA:NOT
Germany Market

Novartis AG (NOT) Technical Analysis

Compare
23 Followers

Summary of all the Indicators

Overall Consensus
Neutral
9Bullish
4Neutral
8Bearish
Technical Analysis Consensus
Buy
3Bullish
4Neutral
2Bearish
Moving Average Consensus
Neutral
6Bullish
0Neutral
6Bearish
Novartis’s (NOT) Moving Averages Convergence Divergence (MACD) indicator is 1.76, suggesting Novartis is a Buy.
Novartis’s (NOT) 20-Day exponential moving average is 101.16, while Novartis’s (NOT) share price is €100.84, making it a Sell.
Novartis’s (NOT) 50-Day exponential moving average is 95.93, while Novartis’s (NOT) share price is €100.84, making it a Buy.

Novartis AG (NOT) Pivot Points

Jun 23, 2025, 03:19 PM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
99.60
100.08
101.04
101.52
102.48
102.96
103.92
Fibonacci
100.08
100.63
100.97
101.52
102.07
102.41
102.96
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Novartis AG (NOT) Moving Averages

Jun 23, 2025, 03:19 PM
Period
Simple
Exponential
MA5
101.62Sell
101.67Sell
MA10
102.64Sell
102.00Sell
MA20
101.89Sell
101.16Sell
MA50
94.76Buy
95.93Buy
MA100
86.49Buy
89.92Buy
MA200
81.60Buy
84.52Buy
Novartis’s (NOT) 10-Day exponential moving average is 102.00, while Novartis’s (NOT) share price is €100.84, making it a Sell.
Novartis’s (NOT) 100-Day exponential moving average is 89.92, while Novartis’s (NOT) share price is €100.84, making it a Buy.
Novartis’s (NOT) stock price is €100.84 and Novartis’s (NOT) 50-day simple moving average is 94.76, creating a Buy signal.
Novartis’s (NOT) stock price is €100.84 and Novartis’s (NOT) 100-day simple moving average is 86.49, creating a Buy signal.
Novartis’s (NOT) stock price is €100.84 and Novartis’s (NOT) 200-day simple moving average is 81.60, creating a Buy signal.

Novartis AG (NOT) Technical Indicators

Jun 23, 2025, 03:19 PM
Name
Value
Implied Action
RSI (14)
53.18
Neutral
STOCH (9,6)
14.98
Buy
STOCHRSI (14)
20.71
Neutral
MACD (12,26)
1.76
Buy
ADX (14)
-
Williams %R
-94.58
Buy
CCI (14)
-46.19
Neutral
ATR (14)
1.52
-
Ultimate Oscillator
48.64
Neutral
ROC
-0.65
Sell
Novartis’s (NOT) Relative Strength Index (RSI) is 53.18, creating a Neutral signal.
Novartis’s (NOT) Commodity Channel Index (CCI) is -46.19, creating a Neutral signal.
Novartis’s (NOT) Price Rate of Change (ROC) is -0.65, creating a Sell signal.

FAQ

Is NOT a Buy, Hold, or Sell?
Based on NOT’s technical indicators, NOT is a Hold.
    What is NOT’s RSI (14)?
    NOT’s RSI (14) is 53.18, which suggests NOT is a Neutral.
      What is NOT’s MACD?
      NOT’s MACD is 1.76, which suggests NOT is a Buy.
        What is NOT’s 5-day moving average?
        NOT’s 5-day moving average is 101.62, which suggests NOT is a Sell.
          What is NOT’s 20-day moving average?
          NOT 20-day moving average is 101.89, which suggests NOT is a Sell.
            What is NOT’s 50-day moving average?
            NOT’s 50-day moving average is 94.76, which suggests NOT is a Buy.
              What is NOT’s 200-day moving average?
              NOT’s 200-day moving average is 81.60, which suggests NOT is a Buy.
                What is NOT’s Williams % R (14)?
                NOT’s Williams % R (14) is -94.58, which suggests NOT is a Buy.
                  What is NOT’s CCI (14)?
                  NOT’s CCI (14) is -46.19, which suggests NOT is a Neutral.
                    What is the share price of Novartis?
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis